Two Sigma Investments
SGMT icon

Two Sigma Investments’s Sagimet Biosciences SGMT Stock Holding History

Two Sigma Investments’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Sell
40,132
-2,400
-6% -$13.4K ﹤0.01% 4263
2025
Q4 		$252K Sell
42,532
-8,659
-17% -$62.2K ﹤0.01% 3669
2025
Q3 		$351K Buy
51,191
+38,146
+292% +$309K ﹤0.01% 3147
2025
Q2 		$99.4K Sell
13,045
-36,804
-74% -$155K ﹤0.01% 3000
2025
Q1 		$163K Sell
49,849
-584
-1% -$2.45K ﹤0.01% 2895
2024
Q4 		$227K Sell
50,433
-133,205
-73% -$675K ﹤0.01% 2835
2024
Q3 		$509K Buy
183,638
+109,654
+148% +$338K ﹤0.01% 2467
2024
Q2 		$253K Sell
73,984
-1,237
-2% -$5.67K ﹤0.01% 2655
2024
Q1 		$408K Buy
75,221
+31,321
+71% +$225K ﹤0.01% 2425
2023
Q4 		$238K Buy
+43,900
New +$207K ﹤0.01% 2770

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Investments's SGMT Position: Q1 2026 in Review

Two Sigma Investments reduced its Sagimet Biosciences (SGMT) stake by 5.6% in Q1 2026, selling an estimated $13.4K and leaving 40,132 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #4263.

Two Sigma Investments first reported a position in SGMT in Q4 2023 and has held it in 10 quarters since. The position peaked at $509K in Q3 2024. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Two Sigma Investments held 40,132 shares of Sagimet Biosciences worth $210K as of Q1 2026.
  • Two Sigma Investments sold 2,400 Sagimet Biosciences shares in Q1 2026, an estimated $13.4K.
  • Sagimet Biosciences made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4263 holding.
  • Two Sigma Investments first reported a position in Sagimet Biosciences in Q4 2023 and has held it in 10 quarters since.
  • Two Sigma Investments's Sagimet Biosciences position peaked at $509K in Q3 2024.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.